Clinical trial · Observational
Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Elderly Cancer Patients Within a Comprehensive Geriatric Assessment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Over the last few years, there has been a considerable interest in the development of screening tools to assess the capability of elderly cancer patients to tolerate anti-cancer treatment. Therefore, the NCCN Guidelines in Senior Adult Oncology recommend an assessment of co-morbid conditions that are likely to interfere with cancer treatment and tolerability. As presbyacusis is common in an older population, elderly cancer patients are at high risk for social isolation and a reduced quality of life. Therefore, in this project the investigators aim to validatie uHear™ as a quick and reliable screening tool to screen for presbyacusisf in routine clinical oncology practice.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Hearing Loss | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Validation of uHear™ as a screening tool to detect hearing loss in elderly cancer patients
- timeFrame
- Baseline
Secondary outcomes (5)
- measure
- To determine the prevalence of presbyacusis in an elderly cancer population
- timeFrame
- Baseline
- measure
- To compare objective and subjective hearing screening measures
- timeFrame
- Baseline
- measure
- To measure hearing impairment in G8 positive patients compared with G8 negative patients
- timeFrame
- Baseline
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients should have reached the age of 70 or more at enrolment * Histologically confirmed diagnosis of solid cancer or hematologic malignancy. All stages of cancer are eligible * Patients should be fluent in Dutch or French * Patients must receive their primary oncology care in the participating hospital * Patients should be cognitively capable of performing the audiology assessment * Patients should have signed informed consent Exclusion Criteria: * Patients who do not match the above inclusion criteria * Patients who are visiting the oncology clinic for a second opinion and do not wish to be treated in this clinic * Patients presenting with clinically diagnosed Ménière's disease, retrocochlear hearing loss, autoimmune inner ear disease, fluctuating hearing loss or a history of sudden sensory neural hearing loss * Patients who already have a hearing aid or a previously diagnosed hearing loss
References
Publications (1)
- RESULTLycke M, Boterberg T, Martens E, Ketelaars L, Pottel H, Lambrecht A, Van Eygen K, De Coster L, Dhooge I, Wildiers H, Debruyne PR. Implementation of uHear--an iOS-based application to screen for hearing loss--in older patients with cancer undergoing a comprehensive geriatric assessment. J Geriatr Oncol. 2016 Mar;7(2):126-33. doi: 10.1016/j.jgo.2016.01.008. Epub 2016 Feb 26. PMID 26924571